Using Evidence to Fill Gaps in the Care of Transgender People
- 1 November 2020
- journal article
- editorial
- Published by Elsevier BV in Endocrine Practice
- Vol. 26 (11), 1387-1388
- https://doi.org/10.4158/ep-2020-0266
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender WomenEndocrine Practice, 2020
- Care of Transgender PersonsThe New England Journal of Medicine, 2019
- Care of the Transgender PatientAnnals of Internal Medicine, 2019
- Care of the Transgender PatientAnnals of Internal Medicine, 2019
- Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databasesBMJ, 2019
- Prolactin Levels Do Not Rise Among Transgender Women Treated With Estradiol and SpironolactoneEndocrine Practice, 2018
- Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate TreatmentLGBT Health, 2017
- Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individualsJournal of Clinical & Translational Endocrinology, 2015
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7International Journal of Transgenderism, 2012